US drug approvals
72 approvals with a product on the US market
- Ibrutinib ANDA211182 · approved 8 Sep 2026
- Afatinib Dimaleate ANDA210750 · approved 14 Jul 2026
- Losartan Potassium And Hydrochlorothiazide ANDA219869 · approved 27 May 2026
- Nilotinib Hydrochloride ANDA209651 · approved 19 Nov 2025
- Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide ANDA209242 · approved 6 Oct 2025
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.